Skip to main content

Benefits of Breast Cancer Index

Videos - Interview with the Innovators
Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.
Related Items
Patients Are at the Heart of Everything We Do
Jenny Fox, Wendy Interiano, Mark Peters II, PharmD, Shannon Stempkowski
Videos published on November 17, 2023 in Interview with the Innovators
A Passion for Scientific Innovation and a Company Culture That Values Customers Drive the Teams at Genmab to Discover Cutting-Edge Solutions for People with Cancer
Brad Bailey, Chris Cozic
Videos published on October 19, 2022 in Interview with the Innovators
Genmab Unleashes the Power of Strategic Alliances to Advance the Science of Therapeutic Antibodies for People with Cancer
Robyn Bilmes, Leslie Amendola
Videos published on September 28, 2022 in Interview with the Innovators
Genmab Is Developing a World-Class Antibody Portfolio with the Hope to Bring the Right Cancer Therapy for the Right Patient
Kate Sasser, Hisham Hamadeh
Videos published on July 8, 2022 in Interview with the Innovators
Genmab Is Ready to Enter the US Market to Help Improve the Lives of People with Cancer
Ron Graybill, Brad Bailey
Videos published on June 2, 2022 in Interview with the Innovators
Last modified: August 30, 2021